CAS No. |
Product Name |
Formula |
|
ENDOTHELIN RECEPTOR SUBTYPE B HUMAN |
|
|
EPOXY TISSUE STAIN |
|
|
EBV |
|
|
ETHYL 1,6-DIMETHYL-4-(6-NITRO-1,3-BENZODIOXOL-5-YL)-2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE |
C16H17N3O7 |
|
ETHYL 4-(2-METHOXYPHENYL)-1,6-DIMETHYL-2-OXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBOXYLATE |
C16 H20 N2 O4 |
|
ETHYL 4-[2-(BENZYLOXY)PHENYL]-6-METHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE |
C21H22N2O3S |
64700-55-6
|
EFUAMIDE |
C15 H15 N O3 |
|
ETHYL 2-(4-CHLOROBENZENESULFONAMIDO)ACETATE |
C10 H12 Cl N O4 S |
299949-24-9
|
ETHYL 6-METHYL-4-(4-METHYLPHENYL)-2-OXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBOXYLATE |
C15 H18 N2 O3 |
|
ETHANESULFONIC ACID (3-CHLORO-4-HYDROXY-PHENYL)-AMIDE |
C8 H10 Cl N O3 S |
|
ETHANESULFONIC ACID (4-HYDROXY-PHENYL)-AMIDE |
C8 H11 N O3 S |
|
ETHYL 4-(([1-(4-ETHYLPHENYL)-5-OXO-3-PYRROLIDINYL]CARBONYL)AMINO)BENZOATE |
C22 H24 N2 O4 |
|
ETHYL 2,2-DIFLUORO-3-HYDROXYBUTANOATE |
C6 H10 F2 O3 |
|
ETHYL N-(3-CHLORO-2-METHYLPHENYL)CARBAMATE |
C10 H12 Cl N O2 |
|
ETHYL N-(2-BROMO-4-METHYLPHENYL)CARBAMATE |
C10 H12 Br N O2 |
|
ETHYL 2-[(4-TERT-BUTYLBENZOYL)AMINO]-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHENE-3-CARBOXYLATE |
C21 H25 N O3 S |
|
ETHYL 2-AMINO-6-TERT-BUTYL-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE |
C15 H23 N O2 S |
|
ET 6-AMINO-2-(CHLOROMETHYL)-5-CYANO-4-(4-METHOXYPHENYL)-4H-PYRAN-3-CARBOXYLATE |
C17 H17 Cl N2 O4 |
|
ETHYL 6-AMINO-2-(CHLOROMETHYL)-5-CYANO-4-(2-THIENYL)-4H-PYRAN-3-CARBOXYLATE |
C14 H13 Cl N2 O3 S |
|
ETHYL 6-AMINO-2-(CHLOROMETHYL)-5-CYANO-4-(2-FLUOROPHENYL)-4H-PYRAN-3-CARBOXYLATE |
C16 H14 Cl F N2 O3 |
108274-38-0
|
ETHYL 4-CHLORO-2-NITROPHENYLACETATE |
C10 H10 Cl N O4 |
|
ETHYL 5-CHLORO-2-CYANO-5-PHENYLPENTA-2,4-DIENOATE |
C14 H12 Cl N O2 |
14174-93-7
|
ETHYL 4-HYDROXY-1-OXO-1,2-DIHYDROISOQUINOLINE-3-CARBOXYLATE |
C12 H11 N O4 |
|
ETHYL 2-(2-((2-(METHOXYCARBONYL)-3-THIENYL)AMINO)VINYL)-5-OXO-5,10-DIHYDROBENZO(G)QUINOLINE-3-CARBOXYLATE |
C24 H20 N2 O5 S |
|
ETHYL 2-[5-(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOL-3-YL]ACETATE |
C12 H12 Cl N3 O2 |
|
ETHYL N-(2-CYANO-2-(2-[3-(TRIFLUOROMETHYL)PHENYL]HYDRAZONO)ACETYL)CARBAMATE |
C13 H11 F3 N4 O3 |
|
ETHYL 2-[(3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZIN-6-YL)AMINO]ACETATE |
C7 H10 N4 O4 |
86818-19-1
|
ETHYL 2-(3-AMINO-4-HYDROXYPHENYL)ACETATE |
C10 H13 N O3 |
5408-04-8
;66508-93-8
|
ETHYL 2-(HYDROXYIMINO)-3-OXOBUTANOATE |
C6 H9 N O4 |
289651-81-6
|
ETHYL 2-(1H-PYRROL-1-YL)-1,3-BENZOTHIAZOLE-6-CARBOXYLATE |
C14 H12 N2 O2 S |
103646-25-9
|
ETHYL 2-METHYL-1,3-BENZOTHIAZOLE-6-CARBOXYLATE |
C11 H11 N O2 S |
|
EMOLECULES 2566820 |
C15 H13 N O3 |
162396-10-3
|
ETHYL 2,4-DIOXO-3-(1,1,1-TRIPHENYL-LAMBDA5-PHOSPHANYLIDENE)PENTANOATE |
C25 H23 O4 P |
6314-22-3
|
ETHYL 5-ACETYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE |
C11 H15 N O3 |
70070-22-3
|
ETHYL 5-BROMO-3-METHYL-1H-INDOLE-2-CARBOXYLATE |
C12 H12 Br N O2 |
299927-12-1
|
ETHYL 1-(2-HYDROXYETHYL)-2-METHYL-1H-BENZIMIDAZOLE-5-CARBOXYLATE |
C13 H16 N2 O3 |
126081-03-6
;296876-23-8
|
ETHYL 2-(1-OXO-4-PHENYLPHTHALAZIN-2(1H)-YL)ACETATE |
C18 H16 N2 O3 |
853333-95-6
|
ETHYL 2-(1-OXO-4-PHENYL-2(1H)-PHTHALAZINYL)PROPANOATE |
C19 H18 N2 O3 |
|
ETHYL 2-AMINO-4-CHLORO-5-NITROBENZOATE |
C9 H9 Cl N2 O4 |
|
ETHYL 1-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-1H-PYRROLE-2-CARBOXYLATE |
C13 H10 Cl F3 N2 O2 |
|
ETHYL MORPHOLINOACETATE HYDROCHLORIDE |
C8 H15 N O3 . Cl H |
|
ENDOPEPTIDASE K, IMMOBILIZED ON EUPERGIT(R) C |
|
560-66-7
|
EBURICOIC ACID |
C31 H50 O3 |
|
EPICASTASTERONE |
C28 H48 O5 |
76994-07-5
|
EUPHROSIDE |
C16 H24 O10 |
78536-37-5
|
EXCISANIN A |
C20 H30 O5 |
|
ECD AGAR WITH MUG, HICROME(TM) |
|
|
EDTA STABILIZER |
|
|
ELECTRODE CLEANING SOLUTION |
|
|
ELUANT |
|
|
EOSIN METHYLENE BLUE AGAR, LEVINE |
|
67621-28-7
|
EMPIGEN CDR 10 |
|
|
EN3HANCE SPRAY SURFACE AUTORADIOGRAPHY ENHANCER |
|
|
ENDOTHELIN I OLIGONUCLEOTIDE HYBRIDIZATION PROBE |
|
|
ENKEPHALIN OLIGONUCLEOTIDE HYBRIDIZATION PROBE |
|
|
ENLIGHTNING(TM) RAPID AUTORADIOGRAPHY ENHANCER |
|
|
ENTENSIFY(R) UNIVERSAL AUTORADIOGRAPHY ENHANCER |
|
|
ERYTHROSIN 239 |
|
|
ESCULIN IRON AGAR |
|
|
ETCHANT BUFFERED OXIDE |
|
|
ETEPHOLICLIN |
|
|
ETHYL (C2) NARROW-PORE MEDIA-REVERSE PHASE |
|
|
ETHYL VIOLET AZIDE BROTH |
|
|
EUGON AGAR |
|
|
EXENDIN [9-39] PEPTIDE |
|
|
EXPRE35S35S PROTEIN LABELING MIX, [35S]- |
|
|
ETHYL 2-(4-AMINO-3-METHYLPHENYL)-3,3,3-TRIFLUORO-2-HYDROXYPROPANOATE |
C12 H14 F3 N O3 |
254732-50-8
|
ETHYL 2-(4-AMINO-3-METHOXYPHENYL)-3,3,3-TRIFLUORO-2-HYDROXYPROPANOATE |
C12 H14 F3 N O4 |
175276-59-2
|
ETHYL 5-(4-CHLOROPHENYL)-2-(TRIFLUOROMETHYL)-3-FUROATE |
C14 H10 Cl F3 O3 |
111787-82-7
|
ETHYL 2-ACETYL-4-(4-CHLOROPHENYL)-4-OXOBUTANOATE |
C14 H15 Cl O4 |
111787-84-9
|
ETHYL 5-(4-CHLOROPHENYL)-2-METHYL-3-FUROATE |
C14 H13 Cl O3 |
17515-73-0
|
ETHYL 5-METHYL-2-(TRIFLUOROMETHYL)-3-FUROATE |
C9 H9 F3 O3 |
|
ETHYL 5-AMINO-3-[4-(TERT-BUTYL)PHENYL]-4-OXO-3,4-DIHYDROTHIENO[3,4-D]PYRIDA ZINE-1-CARBOXYLATE |
C19 H21 N3 O3 S |
|
ETHYL 2-(([3-(2,6-DICHLOROPHENYL)-5-METHYL-4-ISOXAZOLYL]CARBONYL)AMINO)ACETATE |
C15 H14 Cl2 N2 O4 |
85946-11-8
|
ETHYL 4-AMINO-3-BROMO-5-CYANO-2-HYDROXYBENZOATE |
C10 H9 Br N2 O3 |
71254-75-6
|
ETHYL 3-AMINO-4-(4-MORPHOLINYL)BENZOATE |
C13 H18 N2 O3 |
231285-86-2
|
ETHYL 1-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLATE |
C8 H9 F3 N2 O2 |
680211-86-3
|
ETHYL 4-CHLORO-2-(TRIFLUOROMETHYL)QUINOLINE-6-CARBOXYLATE |
C13 H9 Cl F3 N O2 |
|
ETHYL 2-(5-PIPERIDINO-2H-1,2,3,4-TETRAAZOL-2-YL)PROPANOATE |
C11 H19 N5 O2 |
58559-52-7
|
ETHYL (3-AMINOPHENOXY)ACETATE |
C10 H13 N O3 |